Search
for
Sort by
Research 31–60 of 565
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females
- Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome
- The Role of Androgens in Health and Disease in Females: A Narratıve Review
- Hirsutism in the Adolescent Female
- Hormones
- Compendium of polycystic ovarian syndrome and its relevance in glycation and diabetes
- Polycystic Ovary Syndrome: Conditions, Genetics and Current Cure
- The Effects of Oral 5-alpha Reductase Inhibitors on Penile Intracavernosal Pressures and Penile Morphology in Rat Model.
- Exploring phytoandrogens: A review of their potential in health and medicine
- Les hormones sexuelles et la peau : questionnaire à l'attention des vétérinaires praticiens. Mise à jour bibliographique et synthèse
- Diagnosis of an indistinct Leydig cell tumor by positron emission tomography-computed tomography
- Gut–ovary axis and multiomic insights into PCOS in a DHEA-induced rat model
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Morphometric-stereological and functional epididymal alterations and a decrease in fertility in rats treated with finasteride and after a 30-day post-treatment recovery period
- Hypothalamic DNA methylation in rats with dihydrotestosterone‐induced polycystic ovary syndrome: effects of low‐frequency electro‐acupuncture
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Congenital adrenal hyperplasia
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
- Melatonin Receptors and Their Role in Human Diseases
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Biological effects of human placental extracts - variations in manufacturing methods and compositions
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- Periodontal Manifestations of Diseases/Conditions Related with Female Sex Steroid Hormones